UMIN-CTR Clinical Trial

Recruitment status Recruiting
Unique ID issued by UMIN UMIN000024590
Receipt No. R000028300
Official scientific title of the study The investiaton of comprehenve genetic mutation in patients with HCC and hepatitis.
Date of disclosure of the study information 2016/10/27
Last modified on 2016/10/27 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The investiaton of comprehenve genetic mutation in patients with HCC and hepatitis.
Title of the study (Brief title) The investiaton of comprehenve genetic mutation in patients with HCC and hepatitis.
Region
Japan

Condition
Condition HCC/hepatitis
Classification by specialty
Hepato-biliary-pancreatic medicine
Classification by malignancy Malignancy
Genomic information YES

Objectives
Narrative objectives1 To clatify the genetic mutation of the patients with HCC and hepatitis.
Basic objectives2 Bio-availability
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The genetic mutation of Tumor, Non tumor, buffy coat, plasma in patients with HCC and hepatitis.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Gene
Interventions/Control_1 We collect DNA from tumor, non-tumor, buffy coat, plasma.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
100 years-old >
Gender Male and Female
Key inclusion criteria patients who conntract HCC or hepatitis
Key exclusion criteria women who are pregnant
Target sample size 50

Research contact person
Name of lead principal investigator Tatsuro Kanda
Organization Chiba university
Division name Department of gastroenterology
Address 1 8 1 Inohana Cyuo ward Chiba city
TEL 043-222-7171
Email kandat-cib@umin.ac.jp

Public contact
Name of contact person Tatsuro Kanda
Organization Chiba university
Division name gastroenterology and neohrology
Address 1 8 1 Inohana Cyuo ward Chiba city
TEL 043-222-7171
Homepage URL
Email kandat-cib@umin.ac.jp

Sponsor
Institute Chiba university
Institute
Department

Funding Source
Organization Chiba university
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 10 Month 27 Day

Progress
Recruitment status Recruiting
Date of protocol fixation
2016 Year 04 Month 20 Day
Anticipated trial start date
2016 Year 04 Month 20 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 10 Month 27 Day
Last modified on
2016 Year 10 Month 27 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028300